Shares of Addus HomeCare Corporation (NASDAQ:ADUS – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the eleven ratings firms that are presently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company. The average 1 year price target among brokerages that have updated their coverage on the stock in the last year is $131.2222.
Several equities research analysts have recently issued reports on ADUS shares. Wall Street Zen cut shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research report on Saturday, March 21st. Royal Bank Of Canada reiterated an “outperform” rating and set a $139.00 price objective on shares of Addus HomeCare in a research report on Wednesday, February 25th. Stephens reduced their price target on shares of Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating on the stock in a research report on Wednesday, February 25th. KeyCorp restated an “overweight” rating on shares of Addus HomeCare in a research report on Wednesday, February 25th. Finally, Citizens Jmp restated a “market outperform” rating and issued a $142.00 price target on shares of Addus HomeCare in a research report on Monday, May 18th.
View Our Latest Analysis on Addus HomeCare
Addus HomeCare Trading Down 0.7%
Addus HomeCare (NASDAQ:ADUS – Get Free Report) last released its quarterly earnings data on Monday, May 4th. The company reported $1.62 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.52 by $0.10. The firm had revenue of $363.50 million for the quarter, compared to analysts’ expectations of $366.41 million. Addus HomeCare had a net margin of 6.89% and a return on equity of 9.80%. The company’s revenue for the quarter was up 7.7% compared to the same quarter last year. During the same quarter last year, the business posted $1.42 earnings per share. On average, equities analysts predict that Addus HomeCare will post 6.24 earnings per share for the current fiscal year.
Insider Buying and Selling
In related news, EVP David W. Tucker sold 379 shares of the business’s stock in a transaction on Wednesday, February 25th. The shares were sold at an average price of $105.36, for a total value of $39,931.44. Following the sale, the executive vice president owned 10,423 shares in the company, valued at approximately $1,098,167.28. The trade was a 3.51% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Roberton James Stevenson sold 284 shares of the business’s stock in a transaction on Wednesday, February 25th. The stock was sold at an average price of $105.36, for a total transaction of $29,922.24. Following the completion of the sale, the executive vice president owned 14,030 shares in the company, valued at $1,478,200.80. This represents a 1.98% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 17,288 shares of company stock valued at $1,832,133 in the last three months. Corporate insiders own 4.50% of the company’s stock.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently bought and sold shares of the company. TimesSquare Capital Management LLC boosted its stake in Addus HomeCare by 6.2% during the third quarter. TimesSquare Capital Management LLC now owns 418,348 shares of the company’s stock worth $49,361,000 after buying an additional 24,301 shares during the period. Burney Co. purchased a new position in Addus HomeCare during the fourth quarter worth $1,841,000. Public Sector Pension Investment Board boosted its stake in Addus HomeCare by 14.4% during the third quarter. Public Sector Pension Investment Board now owns 70,827 shares of the company’s stock worth $8,357,000 after buying an additional 8,893 shares during the period. Capital Research Global Investors boosted its stake in Addus HomeCare by 9.0% during the third quarter. Capital Research Global Investors now owns 1,201,560 shares of the company’s stock worth $141,772,000 after buying an additional 99,262 shares during the period. Finally, Vanguard Group Inc. boosted its stake in Addus HomeCare by 2.9% during the third quarter. Vanguard Group Inc. now owns 1,298,104 shares of the company’s stock worth $153,163,000 after buying an additional 36,674 shares during the period. 95.35% of the stock is owned by hedge funds and other institutional investors.
About Addus HomeCare
Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.
The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.
Further Reading
- Five stocks we like better than Addus HomeCare
- Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus?
- Kiniksa Pharmaceuticals Still Has Room to Run After 100% Rally
- MarketBeat Week in Review – 05/18 – 05/22
- SpaceX IPO: Opportunity? Or the Ultimate Hype Trade?
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.
